Diagnosis & Disease Information

January 27, 2023

Tecarfarin is a novel oral vitamin K antagonist with a similar mechanism of action to warfarin, though it is metabolized differently.

Brian Park, PharmD

August 31, 2022

MK-2060 is an investigational monoclonal antibody designed to inhibit the activation of Factor XI and its ability to activate downstream proteins.

Next post in End-Stage Renal Disease

Comorbidities Up Among Patients With ESKD, Concomitant Psoriasis